• Novel IT Platform Helps Novartis Gain Control of Clinical Imaging Data

    Nov 16 | eCliniqua | Researchers at Novartis in Basel have developed a powerful new electronic data capture (EDC) hub for clinical data that has allowed its investigators to control data across multiple trials as never before, according to David Tuch, head of clinical imaging at the Novartis Institute for Biomedical Research, Switzerland. “This is a game changer for managing clinical trials at Novartis.”

    Nov 15, 2010

  • Most Trials Now Eligible for Design Simulation

    New simulation tool expands the range of eligible trials. By Deb Borfitz November 16, 2010 | The first upgrade to a one of a kind simulation tool co developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical

    Nov 14, 2010

  • Databases Down Under

    Nov 15 | eCliniqua | BRISBANE—At TRX10, Translational Research Excellence, held last month in Brisbane, amid a wide-ranging program covering everything from stem cell models to commercializing academic innovations, translational approaches to cancer and central nervous system disease to trial design, discussion turned to repositories for genetic and clinical data. Researchers encouraged one another to share raw data, analyses, and clinical findings to further research and enable advances in medicine.

    Nov 14, 2010

  • The IP Picture for iPS Cells

    Nov 15 | eCliniqua | Expert Commentary | An exciting recent advance in medicine has been the generation of induced pluripotent stem (iPS) cells which are derived from somatic cells, rather than embryos, through a process of “de-differentiation.” But the advance raises important intellectual property and patent questions.

    Nov 14, 2010

  • Covance Signs 10-Year Deal With Sanofi, Buys Sites

    Nov 11 | News Brief | Covance has closed its transactions with sanofi-aventis to become its R&D partner over the next 10 years and to purchase sanofi-aventis' Porcheville, France and Alnwick, United Kingdom sites.

    Nov 5, 2010

  • Perceptive Incorporates IBM Technology into eClin Platform

    Nov 8 | News Brief | Perceptive Informatics has incorporated IBM's WebSphere portal and Tivoli Access Manager into its eClinical platform, which provides support for its eClinical Suite.

    Nov 5, 2010

  • Lilly, PPD Win Clinical Research Sites Award

    Nov 5 | News Brief | The Site Solutions Summit, an annual conference of premier clinical research sites from around the world, voted to present their 2010 Site Solutions Summit Eagle Awards to Eli Lilly and Company, as the top pharmaceutical firm, and PPD, as the top contract research organization (CRO).

    Nov 5, 2010

  • Faulty Research Pulled, Subsequent Trials Questioned

    Nov 1 | News & Observer | Joseph Nevins, a professor and director of Duke's Center for Applied Genomics and Technology, has asked that the Journal of Clinical Oncology retract work finding a genetic link to cancer patients' drug response that he submitted with a colleague in 2007.

    Oct 31, 2010

  • BioClinica Provides EDC to Pharma

    Oct 18 | News Brief | BioClinica has signed a three-year, multi-million dollar agreement for enterprise-wide EDC technology and data management services with a global, multibillion dollar division of a Top 10 pharmaceutical company.

    Oct 17, 2010

  • HUYA, Quintiles Develop Cancer Drug in China

    Oct 18 | News Brief | HUYA Bioscience International and Quintiles have announced an agreement to co-develop a new cancer drug, HBI-8000, sourced in China by HUYA.

    Oct 17, 2010

  • Most Trials Now Eligible for Design Simulation

    Oct 18 | eClinica | The first upgrade to a one-of-a-kind simulation tool co-developed by Tessella and Berry Consultants significantly enlarges the proportion of clinical studies that can benefit from simulation of the design.

    Oct 17, 2010

  • National eHealth Collaborative Fall Courses

    Sept 24 | News Brief | The National eHealth Collaborative (NeHC) has announced the course schedule for the Fall 2010 semester of Nationwide Health Information Network (NHIN) University.

    Sep 23, 2010

  • Ariana and FDA Look for Biomarker Signatures

    Sept 22 | News Brief | Ariana Pharma and the US Food and Drug Administration (FDA) have entered into a partnership. Ariana Pharma is providing its KEM Biomarker technology to help enable FDA reviewers to analyze pharmacogenomic data combined with patient characteristics for biomarker signatures

    Sep 21, 2010

  • Which Way Forward for e-Sourcing?

    Sept 21 | eCliniqua | If clinical trial data were sourced electronically rather than on paper, pharmaceutical companies could reap huge savings—most notably by eliminating site monitoring for purposes of source data verification (SDV). Yet e-sourcing remains a relatively rare practice, in part because sites find it inconvenient to enter data directly into electronic data capture (EDC) systems.

    Sep 21, 2010